Covered recipient · General Payments record
KEITH S KAYE
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$212,495.67
- Reported across 118 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $38,999.00 | 11 |
| Travel and Lodging | $9,529.53 | 6 |
| Grant | $457.05 | 1 |
| Food and Beverage | $196.22 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $35,035.65 | 11 |
| ABBVIE INC. | $10,982.23 | 9 |
| BECTON, DICKINSON AND COMPANY | $1,740.00 | 1 |
| Merck Sharp & Dohme Corporation | $1,395.00 | 1 |
| Melinta Therapeutics, Inc. | $28.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5,000.00 | 01/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103135961 | CMS |
| ABBVIE INC. | $388.91 | 01/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104190910 | CMS |
| ABBVIE INC. | $430.87 | 01/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104190912 | CMS |
| ABBVIE INC. | $45.65 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104044236 | CMS |
| ABBVIE INC. | $21.74 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104044238 | CMS |
| ABBVIE INC. | $22.20 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104044240 | CMS |
| ABBVIE INC. | $2,362.50 | 11/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103135963 | CMS |
| ABBVIE INC. | $2,700.00 | 11/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103135965 | CMS |
| ABBVIE INC. | $10.36 | 11/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1104190914 | CMS |
| Becton, Dickinson and Company | $1,740.00 | 08/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1127612990 | CMS |
| GlaxoSmithKline, LLC. | $1,950.00 | 02/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116256671 | CMS |
| GlaxoSmithKline, LLC. | $7,054.13 | 02/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116334613 | CMS |
| GlaxoSmithKline, LLC. | $975.00 | 06/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116659397 | CMS |
| GlaxoSmithKline, LLC. | $617.50 | 06/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116194117 | CMS |
| GlaxoSmithKline, LLC. | $457.05 | 06/14/2024 | Grant | Undisputed | 01/23/2026 | 1116558071 | CMS |
| GlaxoSmithKline, LLC. | $6,175.00 | 06/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116704010 | CMS |
| GlaxoSmithKline, LLC. | $1,027.76 | 09/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116509675 | CMS |
| GlaxoSmithKline, LLC. | $77.71 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116235040 | CMS |
| GlaxoSmithKline, LLC. | $4,550.00 | 12/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116334913 | CMS |
| GlaxoSmithKline, LLC. | $5,850.00 | 12/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116133543 | CMS |
| GlaxoSmithKline, LLC. | $6,301.50 | 12/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116625018 | CMS |
| Melinta Therapeutics, LLC | $28.92 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140486115 | CMS |
| Merck Sharp & Dohme LLC | $1,395.00 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141621158 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.